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Yasuyuki Suzuki* and Yasushi TakasakiAbstract
Postoperative atelectasis should be avoided in surgical patients with impaired pulmonary function. Nasal high-flow
(NHF) therapy delivered by the Optiflow™ system (Fisher & Paykel Healthcare Ltd., Auckland, New Zealand) is a new,
simple device that supplies heated and humidified oxygen gas at >30 L/min via a large-bore nasal cannula. We
herein describe a case in which respiratory support with NHF therapy was useful for the prevention of postoperative
atelectasis recurrence. A 67-year-old man with an upper digestive tract perforation underwent emergency laparoscopic
surgery. He appeared malnourished because of severe untreated diabetes mellitus. The proposed surgery was
uneventfully completed. On postoperative day (POD) 5, he experienced massive atelectasis of the left lower lobe
with desaturation to <90%. After restoration of normal oxygenation by tracheal suction and postural drainage,
noninvasive positive-pressure ventilation (NPPV) at a continuous positive airway pressure (CPAP) of 8 cm H2O
was conducted to prevent repeated atelectasis. Fifteen hours after the cessation of NPPV on POD 7, he developed
recurrence of massive atelectasis. Bronchoscopic suction removed a mucous plaque in the tracheobronchial tree,
and NHF therapy at 40 L/min was subsequently performed, delivering a low level of CPAP instead of NPPV. Under the
respiratory support with NHF therapy, his condition was more stable than with NPPV, and his respiratory rehabilitation
continued uneventfully. In addition, the NHF therapy delivered optimally humidified gas, which improved the bronchial
secretion quality. No further atelectasis occurred throughout the remaining stay in the intensive care unit. We conclude
that respiratory support with NHF therapy may contribute to the prevention of postoperative atelectasis by delivering
CPAP in combination with progressive respiratory rehabilitation.
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Atelectasis is one of the most frequent respiratory compli-
cations after surgery. If massive atelectasis occurs postoper-
atively, the patient may require prolonged mechanical
ventilation, worsening the outcome. Prevention of postop-
erative atelectasis is an important strategy, especially when
managing patients with impaired preoperative pulmonary
function. Nasal high-flow (NHF) therapy delivered by
the Optiflow™ system (Fisher & Paykel Healthcare Ltd.,
Auckland, New Zealand) is a new, simple device that
supplies heated and humidified oxygen at a high flow
rate via a large-bore nasal cannula. The supplied gases
contain a saturated water content of 44 mg H2O/L at 37°C;* Correspondence: ysuzuki1978@gmail.com
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distribution, and reproduction in any mediumthe humidity is optimal for maintenance of mucociliary
function in the peripheral airways. NHF therapy reportedly
delivers low-level positive airway pressure in contrast to
conventional oxygen face masks. Therefore, it may be an ef-
fective supplementary respiratory support technique for the
prevention of postoperative atelectasis. We herein describe
a case in which respiratory support with NHF therapy
helped to prevent the recurrence of postoperative atelec-
tasis in a malnourished patient who underwent emergency
abdominal surgery.Case presentation
A 67-year-old man (weight, 51 kg; height, 162 cm) was re-
ferred to our hospital from a neighboring regional hospital
because of an upper digestive tract perforation caused by
a severe duodenal ulcer. He had pre-existing incompleteCentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Chest X-ray on POD 7 shows massive atelectasis in
the left lower lobe.
Figure 2 Chest X-ray on POD 9 after NHF therapy was applied
shows improvement of the atelectasis.
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as a previous therapeutic history of diabetes mellitus.
Blood chemistry results on admission revealed hypergly-
cemia (548 mg/dL) and a high HbA1c value (11.3%). He
had not taken any medication for his diabetes for the en-
tire previous year. His oral intake had been insufficient for
several days. He appeared malnourished, and his serum al-
bumin value was low at 2.6 g/dL.
He was scheduled to undergo emergency laparoscopic
surgery for peritoneal leverage and direct closure of the
perforated site. The proposed procedure was unevent-
fully completed in 129 min under general anesthesia. He
was extubated after full recovery of consciousness, then
transferred to the intensive care unit (ICU).
Although his respiration remained mostly stable with
an oxygen face mask (5 L/min) while at rest, his cough-
ing effort was limited owing to the insufficient relief of
postoperative pain and exhausted respiratory muscle
activities. On postoperative day (POD) 5, he experi-
enced moderate dyspnea, and his SpO2 rapidly de-
creased to <90% despite an additional oxygen supply.
A chest X-ray showed massive lung collapse of the left
lower lobe. We treated him with frequent tracheal suction
under direct visualization of his vocal cords using an Air-
way Scope™ (Pentax Co., Tokyo, Japan) as well as active
postural drainage while he was sedated with dexmedeto-
midine. He subsequently resumed normal respiration with
the disappearance of the atelectasis. We conducted re-
spiratory support with noninvasive positive-pressure ven-
tilation (NPPV) in continuous positive airway pressure
(CPAP) mode at a PEEP of 8 cm H2O to prevent the re-
currence of atelectasis. As PEEP was gradually decreased
to 5 cm H2O, he sometimes complained of an uncomfort-
ably fixed NPPV face mask. Therefore, he was weaned
from NPPV on POD 7.
Fifteen hours after the cessation of NPPV, his SpO2
unexpectedly decreased to <80%, and he complained of
severe dyspnea. Chest X-ray showed the recurrence of
massive atelectasis in the left lower lobe (Figure 1).
Emergency bronchoscopic suction removed a mucous
plaque that had extensively occluded the bronchial trees.
We chose to alternatively apply NHF therapy at 40 L/min
with an FiO2 of 0.40, delivering low-level positive airway
pressure as respiratory assistance, rather than NPPV be-
cause we expected that the simple device might be more
tolerable and easier to manage. The use of NHF therapy
improved his respiration to a normal, regular pattern, and
he comfortably breathed with inspiration of warmly hu-
midified oxygen gases via his nose and expiration via his
mouth. In addition to NHF therapy and active nutritional
support, a physical therapist introduced bedside respira-
tory rehabilitation every day, which improved his cough-
ing ability. Chest X-ray on POD 9 after the application of
NHF therapy showed improvement of the atelectasis inthe left lower lobe (Figure 2). NHF therapy was discontin-
ued on POD 11, and the atelectasis did not recur through-
out his remaining stay in the ICU until his discharge on
POD 15.
Conclusions
This patient experienced recurrence of massive postop-
erative atelectasis 15 h after NPPV support was termi-
nated. We suspected that his nutritional condition was
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period, even on POD 7. Therefore, his respiratory muscle
activity had not recovered enough to remove the tracheo-
bronchial secretions. In this patient, NPPV effectively pre-
vented atelectasis by delivering 5 cm H2O of CPAP, which
kept the peripheral airways open, as shown in a clinical
study investigating the effect of NPPV on the prevention
of postoperative atelectasis [1]. However, because he could
not tolerate the face mask fixed to the NPPV circuit des-
pite continuous sedation with dexmedetomidine, we chose
to apply NHF therapy to assist respiration rather than per-
form a second trial of NPPV.
NHF therapy is a simple respiratory support technique
that can supply heated, humidified oxygen via a large-bore
nasal cannula at an extremely high flow rate of >30 L/min
up to 60 L/min [2]. In pulmonary care practice, it is re-
portedly useful in the treatment of acute exacerbation
among patients with chronic obstructive pulmonary dis-
ease because it washes out exhaled gases retained in the
nasopharyngeal cavity by supplying gases with a low
oxygen concentration at a high flow rate and promotes
CO2 elimination [3]. Conversely, Parke et al. evaluated
15 surgical ICU patients and reported that NHF therapy
at 35 L/min delivered 2.7 and 1.2 cm H2O of mean positive
airway pressure with mouth closed and open positions, re-
spectively [4]. Although these airway pressures were rela-
tively low, NHF therapy maintained the delivery of positive
pressure to the patient's airway in contrast to a conven-
tional face mask. It is possible that even a low level of posi-
tive airway pressure of <5 cm H2O partially contributed to
preservation of the patency of the peripheral airways, lead-
ing to the preventative effect against re-atelectasis.
NHF therapy has more advantages for postoperative
patients requiring active physical therapy. Respiratory sup-
port with NHF therapy seems to be both less stressful and
more tolerable for patients than NPPV, in which high posi-
tive pressure is continuously supplied through a fixed face
mask. Therefore, patients do not require sedatives for the
maintenance of NHF therapy unless they show mental dis-
turbances before the introduction of NHF therapy. This pa-
tient tended to be more cooperative with the medical staff,
including the physical therapist, under respiratory support
with NHF therapy. When this patient adapted to the NHF
therapy, he comfortably breathed with a normal regular
pattern of inspiration via his nose and expiration via his
mouth. Because optimally humidified gases are supplied at
a high flow rate via the nose, NHF therapy may help to
moisten mucous secretions and promote their clearance
from the peripheral airways [5,6]. The respiratory rehabili-
tation for this patient progressed smoothly and uneventfully
along with the NHF therapy, and his coughing activity re-
covered enough to clear the tracheobronchial secretions.
In summary, we prevented the recurrence of massive
atelectasis in a patient with malnutrition undergoingemergency surgery by conducting respiratory support
with NHF therapy. NHF therapy at a flow rate of 40 L/min
is thought to be an alternative respiratory support to NPPV
set at less than 5 cm H2O of PEEP in terms of preserving
the patency of the peripheral airways. In addition, post-
operative respiratory rehabilitation progressed more
smoothly under NHF therapy in this case, leading to the
recovery of respiratory muscle activity. However, be-
cause the beneficial effects of NHF therapy on the re-
spiratory system have not been fully confirmed in
acutely ill patients, we should carefully monitor the se-
quential changes in the respiratory condition after the
induction of NHF therapy.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
The manuscript was prepared by YS under the supervision of YT. Both
authors read and approved the final manuscript.
Received: 16 August 2013 Accepted: 20 December 2013
Published: 14 January 2014
References
1. Pasquina P, Merlani P, Granier JM, Ricou B: Continuous positive airway
pressure versus noninvasive pressure support ventilation to treat
atelectasis after cardiac surgery. Anesth Analg 2004, 99:1001–1008.
2. Ward JJ: High-flow oxygen administration by nasal cannula for adult and
perinatal patients. Respir Care 2013, 58:98–122.
3. Dysart K, Miller TL, Wolfson MR, Shaffer TH: Research in high flow therapy:
mechanisms of action. Respir Med 2009, 103:1400–1405.
4. Parke R, McGuinness S, Eccleston M: Nasal high-flow therapy delivers low
level positive airway pressure. Br J Anaesth 2009, 103:886–890.
5. Restrepo RD, Walsh BK: Humidification during invasive and noninvasive
mechanical ventilation. Respir Care 2012, 57:782–788.
6. Hasani A, Chapman TH, McCool D, Smith RE, Dilworth JP, Agnew JE:
Domiciliary humidification improves lung mucociliary clearance in
patients with bronchiectasis. Chron Respir Dis 2008, 5:81–86.
doi:10.1186/2052-0492-2-3
Cite this article as: Suzuki and Takasaki: Respiratory support with nasal
high-flow therapy helps to prevent recurrence of postoperative
atelectasis: a case report. Journal of Intensive Care 2014 2:3.
